Genomically confirmed case numbers for SARS-CoV-2 variants of concern and variants under investigation. Category: UncategorisedBy Pharmahealthtalk22 January 2021Leave a commentPost navigationPreviousPrevious post:Guidance: COVID-19: guidance on shielding and protecting people defined on medical grounds as extremely vulnerableNextNext post:Guidance: Avian influenza: PGD templates